Evaluation of viabet capsule, a herbal formulation, as an adjuvant treatment for diabetes mellitus type 2
Phase 3
Recruiting
- Conditions
- Type 2 diabetes.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20191015045124N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Type 2 diabetes according to the 2019 ADA Guideline
Only take metformin tablets
BMI between 25 - 32
Exclusion Criteria
Pregnancy and lactation
Sensitivity to drug
Taking other diabetes medications except metformin
taking drugs that affect blood sugar such as glucocorticoids
Other serious illnesses such as heart failure
Stomach or duodenal ulcer
Use of anticoagulants such as heparin
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood sugar. Timepoint: Starting Study; One month later; Two months later; End of study. Method of measurement: Measurement of serum level in the laboratory.;Hemoglobin A1C. Timepoint: Starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.
- Secondary Outcome Measures
Name Time Method